These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 18032459

  • 21. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ, Scuffham PA, McCollam PL, Newby DE.
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [Abstract] [Full Text] [Related]

  • 22. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes.
    Yan AT, Yan RT, Tan M, Fung A, Cohen EA, Fitchett DH, Langer A, Goodman SG, Canadian Acute Coronary Syndromes 1 and 2 Registry Investigators.
    Arch Intern Med; 2007 May 28; 167(10):1009-16. PubMed ID: 17533203
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease in patients otherwise referred to invasive coronary angiography.
    Kreisz FP, Merlin T, Moss J, Atherton J, Hiller JE, Gericke CA.
    Heart Lung Circ; 2009 Jun 28; 18(3):200-7. PubMed ID: 19250870
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N, Furlong W, Perkins A, Feeny D, Torrance GW.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 28; 15(5):608-15. PubMed ID: 18800005
    [Abstract] [Full Text] [Related]

  • 29. Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
    Marcoff L, Zhang Z, Zhang W, Ewen E, Jurkovitz C, Leguet P, Kolm P, Weintraub WS.
    J Am Coll Cardiol; 2009 Sep 29; 54(14):1271-9. PubMed ID: 19778669
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
    Akker-van Marle ME, Rijnders ME, Dommelen P, Fekkes M, Wouwe JP, Amelink-Verburg MP, Verkerk PH.
    BJOG; 2005 Jun 29; 112(6):820-6. PubMed ID: 15924544
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
    Sculpher MJ, Lozano-Ortega G, Sambrook J, Palmer S, Ormanidhi O, Bakhai A, Flather M, Steg PG, Mehta SR, Weintraub W.
    Am Heart J; 2009 May 29; 157(5):845-52. PubMed ID: 19376310
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Costs of payment in Thai acute coronary syndrome patients.
    Moleerergpoom W, Kanjanavanit R, Jintapakorn W, Sritara P.
    J Med Assoc Thai; 2007 Oct 29; 90 Suppl 1():21-31. PubMed ID: 18431883
    [Abstract] [Full Text] [Related]

  • 37. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
    Roe RH, Lass JH, Brown GC, Brown MM.
    Cornea; 2008 Oct 29; 27(9):1001-7. PubMed ID: 18812762
    [Abstract] [Full Text] [Related]

  • 38. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
    Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.
    Health Technol Assess; 2005 Jul 29; 9(27):iii-iv, ix-xi, 1-158. PubMed ID: 16022802
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.